Literature DB >> 9196168

A subtype-specific peptide-based enzyme immunoassay for detection of antibodies to the G protein of human respiratory syncytial virus is more sensitive than routine serological tests.

J P Langedijk1, A H Brandenburg, W G Middel, A Osterhaus, R H Meloen, J T van Oirschot.   

Abstract

Peptides deduced from the central conserved region (residues 158 to 189) of protein G of human respiratory syncytial virus (HRSV) subtypes A and B were used as antigens in subtype-specific enzyme-linked immunosorbent assays (G-peptide ELISAs). These G-peptide ELISAs were compared with seven other serological assays to detect HRSV infection: ELISAs based on complete protein G, on fusion protein F, and on nucleoprotein N; a complement fixation assay; a virus neutralization test; and ELISAs for the detection of immunoglobulin A (IgA) or IgM antibodies specific for HRSV. In paired serum samples from patients with HRSV infection, more infections were diagnosed by the G-peptide ELISA (67%) than by all other serological tests combined (48%). Furthermore, for 16 of 18 patients (89%), the G-peptide ELISAs were able to differentiate between antibodies against HRSV subtypes A and B. This study shows that peptides corresponding to the central conserved region of the attachment protein G of HRSV can successfully be used as antigens in immunoassays. The G-peptide ELISA appeared to be more sensitive than conventional tests for the detection of HRSV antibody titer rises.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9196168      PMCID: PMC229816          DOI: 10.1128/jcm.35.7.1656-1660.1997

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  11 in total

1.  Type-specific serologic diagnosis of respiratory syncytial virus infection, based on a synthetic peptide of the attachment protein G.

Authors:  J P Langedijk; W G Middel; W M Schaaper; R H Meloen; J A Kramps; A H Brandenburg; J T van Oirschot
Journal:  J Immunol Methods       Date:  1996-06-21       Impact factor: 2.303

2.  Genetic diversity of the attachment protein of subgroup B respiratory syncytial viruses.

Authors:  W M Sullender; M A Mufson; L J Anderson; G W Wertz
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

3.  Identification of variable domains of the attachment (G) protein of subgroup A respiratory syncytial viruses.

Authors:  P A Cane; D A Matthews; C R Pringle
Journal:  J Gen Virol       Date:  1991-09       Impact factor: 3.891

4.  The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins.

Authors:  P R Johnson; M K Spriggs; R A Olmsted; P L Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

Review 5.  Detection, pathogenesis, and therapy of respiratory syncytial virus infections.

Authors:  R C Welliver
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

6.  Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid.

Authors:  H M Geysen; R H Meloen; S J Barteling
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

7.  A subgroup-specific antigenic site in the G protein of respiratory syncytial virus forms a disulfide-bonded loop.

Authors:  B Akerlind-Stopner; G Utter; M A Mufson; C Orvell; R A Lerner; E Norrby
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

8.  Site-directed serology with synthetic peptides representing the large glycoprotein G of respiratory syncytial virus.

Authors:  E Norrby; M A Mufson; H Alexander; R A Houghten; R A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

9.  Nucleotide sequence of the G protein gene of human respiratory syncytial virus reveals an unusual type of viral membrane protein.

Authors:  G W Wertz; P L Collins; Y Huang; C Gruber; S Levine; L A Ball
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

10.  Proposed three-dimensional model for the attachment protein G of respiratory syncytial virus.

Authors:  J P Langedijk; W M Schaaper; R H Meloen; J T van Oirschot
Journal:  J Gen Virol       Date:  1996-06       Impact factor: 3.891

View more
  10 in total

1.  Antibody response to the central unglycosylated region of the respiratory syncytial virus attachment protein in mice.

Authors:  Yoshihiko Murata; Seana C Catherman
Journal:  Vaccine       Date:  2012-06-19       Impact factor: 3.641

2.  Nucleotide and predicted amino acid sequence-based analysis of the avian metapneumovirus type C cell attachment glycoprotein gene: phylogenetic analysis and molecular epidemiology of U.S. pneumoviruses.

Authors:  Rene Alvarez; Humphrey M Lwamba; Darrell R Kapczynski; M Kariuki Njenga; Bruce S Seal
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

Review 3.  Respiratory syncytial virus genetic and antigenic diversity.

Authors:  W M Sullender
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

4.  Humoral response to the central unglycosylated region of the respiratory syncytial virus attachment protein.

Authors:  Yoshihiko Murata; Paula M Lightfoote; Jamie N Biear; Ann R Falsey; Edward E Walsh
Journal:  Vaccine       Date:  2010-07-23       Impact factor: 3.641

5.  Seroepidemiology of human metapneumovirus (hMPV) on the basis of a novel enzyme-linked immunosorbent assay utilizing hMPV fusion protein expressed in recombinant vesicular stomatitis virus.

Authors:  Jessica Leung; Frank Esper; Carla Weibel; Jeffrey S Kahn
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

6.  Reverse epitope mapping of the E2 glycoprotein in antibody associated hepatitis C virus.

Authors:  Amruta S Naik; Ania Owsianka; Brendan A Palmer; Ciaran J O'Halloran; Nicole Walsh; Orla Crosbie; Elizabeth Kenny-Walsh; Arvind H Patel; Liam J Fanning
Journal:  PLoS One       Date:  2017-05-30       Impact factor: 3.240

7.  Features of the Human Antibody Response against the Respiratory Syncytial Virus Surface Glycoprotein G.

Authors:  Kristina Borochova; Katarzyna Niespodziana; Katarina Stenberg Hammar; Marianne van Hage; Gunilla Hedlin; Cilla Söderhäll; Margarete Focke-Tejkl; Rudolf Valenta
Journal:  Vaccines (Basel)       Date:  2020-06-25

8.  Selection of Specific Peptides for Coccidioides spp. Obtained from Antigenic Fractions through SDS-PAGE and Western Blot Methods by the Recognition of Sera from Patients with Coccidioidomycosis.

Authors:  Esperanza Duarte Escalante; María Guadalupe Frías De León; Luz Gisela Martínez García; Jorge Herrera; Gustavo Acosta Altamirano; Carlos Cabello; Gabriel Palma; María Del Rocío Reyes Montes
Journal:  Molecules       Date:  2018-11-30       Impact factor: 4.411

9.  A gp41 MPER-specific llama VHH requires a hydrophobic CDR3 for neutralization but not for antigen recognition.

Authors:  David Lutje Hulsik; Ying-ying Liu; Nika M Strokappe; Simone Battella; Mohamed El Khattabi; Laura E McCoy; Charles Sabin; Andreas Hinz; Miriam Hock; Pauline Macheboeuf; Alexandre M J J Bonvin; Johannes P M Langedijk; David Davis; Anna Forsman Quigley; Marlén M I Aasa-Chapman; Michael S Seaman; Alejandra Ramos; Pascal Poignard; Adrien Favier; Jean-Pierre Simorre; Robin A Weiss; C Theo Verrips; Winfried Weissenhorn; Lucy Rutten
Journal:  PLoS Pathog       Date:  2013-03-07       Impact factor: 6.823

10.  Development of Electrochemiluminescent Serology Assays to Measure the Humoral Response to Antigens of Respiratory Syncytial Virus.

Authors:  Sarah V Maifeld; Bodrey Ro; Hoyin Mok; Marla Chu; Li Yu; Ryan Yamagata; Tansy Leonardson; Vera Chio; Bandita Parhy; Samuel Park; Marcia Carlson; Shushil Machhi; Nancy Ulbrandt; Ann R Falsey; Edward E Walsh; C Kathy Wang; Mark T Esser; Fengrong Zuo
Journal:  PLoS One       Date:  2016-04-12       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.